Hull RD, Van Aken WG, Hirsh J., et al. Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis. Circulation1976:53:696-700.
2.
Salzman EW, Deykin D., Shapiro RM, et al. Management of heparin therapy: controlled prospective trial . N Engl J Med1976;292: 1046-50.
3.
Hull RD, Taylor DW, Hirsh J., et al. Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal-vein thrombosis. Circulation1978;58:898-902.
4.
Hull RD, Hirsh J., Sackett DL, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation1981 :64:622-5.
5.
Hull RD, Hirsh J., Carter CJ, et al. Pulmonary angiography ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan . Ann Intern Med1983;98:891-9.
6.
Hull RD, Hirsh J., Carter CJ et al. Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest1985 ;88:819-28.
7.
Hull RD, Hirsh J., Carter CJ, et al. Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis: a randomized trial. Ann Intern Med1985;102:21-8.
8.
Huisman MV, Buller HE, ten Cate JW, et al. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study. N Engl J Med1986;314:823-8.
9.
Hull R., Raskob G., Coates G., Panju A., Gill GJA new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med1989; 149-2549-55,
10.
Huisman MV, Buller HR, ten Cate JW, et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest1989;95:498-502.
11.
Lensing AWPrandoni P., Brandjes Dpm, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography . N Engl J Med1989;320:342-5.
12.
Huisman MV, Buller HR, ten Cate JW, et al. Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting. Arch Intern Med1989;149:511-3.
13.
Hull R., Raskob G., Coates G., Panju A.Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest1990;97:23-6.
14.
Prospective Investigation of Pulmonary Embolism Diagnosis Investigators.Value of the ventilation-perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis. JAMA1990 ;263:2753-9.
15.
Hull R., Raskob G.Low probability lung scan findings: a need for change. Ann Intern Med1991;114:142-3.
16.
Heijboer H. , Cogo A., Buller HR, Prandoni P. ten Cate JWDetection of deep-vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients. Arch Intérn Med1992-,152:1901-3.
17.
Heijboer H. , Buller HR, Lensing Awa, et al. A comparison of real-time compression ultrasonography versus impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med1993:329:1365-9.
18.
Hull R., Raskob G., Ginsberg J., et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med1994;154:289-97.
19.
Hull RD, Delmore T., Genton E. et al. Warfarin sodium vs low dose heparin in the long-term treatment of venous thrombosis. N Engl J Med1979;301:855-8.
20.
Hull R., Hirsh J., Jay R., et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med1982;307:1676-81.
21.
Hull RD, Raskob GE, Hirsh J., et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med1986,315: 1109-14.
22.
Gallus A., Jackaman J., Tillett J., et al. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet1986;2:1293-6.
23.
Hull R., Raskob G., Rosenbloom D., et al. Heparin for 5 days compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med1990;322:1260-4.
24.
Hull RD, Raskob GERosenbloom DR, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med1992;152:1589-95.
25.
Hull RD, Raskob GE, Pineo GF et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med1992, 326:975-82.
26.
Brandjes Dpm , Heijboer H., Buller HR, et al, Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximo-vein thrombosis . N Engl J Med1992 ;327:1485-9.
27.
Prandoni P. , Lensing AWBuller HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis . Lancet1992;339:441-5.
28.
Lopaciuk S. , Meissner AJ, Filipecki S., et al. Subcutaneous low-molecular-weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicentre trial. Thromb Haemost1992;68:14-18.
29.
Raschke RAReilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med1993;119:874-81.
30.
Simonneau G. , Charbonnier B., Decousus H. et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med1993:153:1541-6.
31.
Lindmarker P., Holmstrom M., Granqvist S., Johnsson H., Locner D.Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep venous thrombosis. Thromb Haemost1994;72:186-90.
32.
de Valk HW, Banga JD, Wester Jwj, et al. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. Ann Intern Med1995;123:
33.
Schulman S. , Rhedin AS, Lindmarker P., et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism . N Engl J Med1995 ;332: 1661-5.
34.
The Urokinase Pulmonary Embolism Trial.A national cooperative study. Circulation1973;47-I:1-108.
35.
Sharma Gvrk , Burleson VA, Sasahara AAEffect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism . N Engl J Med1980;303:842-5.
36.
The UKEP Study Research Group.The UKEP study: multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism. Eur Heart J1987;8:2-10.
37.
Verstraete M., Miller Gah, Bounameaux H., et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation1988;7:353-60.
38.
Goldhaber SZ , Kessler CM, Heit J., et al. A randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet1988;2: 293-8.
39.
Levine MN, Hirsh J., Weitz J., et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest1990;98:1473-9.
40.
Dalla-Volta S. , Palla A., Santolicandro A., et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicentre Study 2. J Am Coll Cardiol1992;20:520-6.
41.
Meyer G., Sors H., Charbonnier B., et al., on behalf of the European Cooperative Study Group for Pulmonary Embolism. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicentre double-blind trial. J Am Coll Cardiol1992;19:239-45.
42.
Goldhaber SZ , Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion, Lancet1993 ; 341:507-11.
43.
Goldhaber SZ , Polak JF, Feldstein ML, et al. Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis . Am J Cardiol1994;73:75-9.
44.
Goldhaber SZ , Agnelli G., Levine MN, et al. Reduced dose bolus alteplase versus conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. Chest1994;106:718-24.
45.
Cook DJ, Cuyatt GH, Laupacis A., Sackett DL, Goldberg RJClinical recommendations using levels of evidence for antithrombotic agents . Chest, 1995;108:227S-30S.
46.
Wolfe MW, Lee RT, Feldstein ML, et al. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J1994; 127:1371-5.
